|Articles|March 10, 2023
News Roundup March 6-March 10
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Racial, Ethnic Inequities Persist in Diabetes Care
Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
FDA Sets Target Date To Expand Dwarfism Care Voxzogo To Younger Children
Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.
FDA Accepts Biologics License Application for Proposed Denosumab Biosimilar
The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women
Show Them The Money
The role of the pharmacy technician has evolved over the past 45 years—but pay hasn’t caught up
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
4
Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48
5